-
Study aim
-
To compare the effects of dexmedetomidine administration before versus after induction of anesthesia on intraoperative fentanyl and isoflurane consumption, hemodynamic responses, and postoperative recovery outcomes in patients undergoing laparoscopic cholecystectomy
-
Design
-
A randomized, double-blind, parallel-group, placebo-controlled clinical trial with a 1:1 allocation ratio.
-
Settings and conduct
-
This study will be conducted at Loghman Hakim Hospital, Tehran, Iran, in eligible patients undergoing elective laparoscopic cholecystectomy. After screening for eligibility and obtaining written informed consent, participants will be randomly assigned to two groups. Anesthetic interventions will be performed according to the study protocol, and intraoperative data and postoperative outcomes will be recorded and compared.
-
Participants/Inclusion and exclusion criteria
-
Adults aged 18–65 years, ASA I–II, undergoing elective laparoscopic cholecystectomy under general anesthesia. Exclusion criteria: dexmedetomidine allergy, significant bradycardia or conduction disorders, major cardiovascular disease, uncontrolled hypertension, severe hepatic impairment, regular opioid use, alpha-2 agonist use within 7 days, pregnancy, or breastfeeding
-
Intervention groups
-
Group A: Dexmedetomidine 1 µg/kg infused over 10 minutes before anesthesia induction, followed by 0.5 µg/kg/h maintenance infusion
Group B: Placebo before induction, followed by dexmedetomidine at the same loading and maintenance doses after induction
-
Main outcome variables
-
Total intraoperative fentanyl consumption (µg/ kg)
Total intraoperative isoflurane consumption (mL)